company background image
688621 logo

Beijing Sun-Novo Pharmaceutical Research SHSE:688621 Stock Report

Last Price

CN¥62.39

Market Cap

CN¥7.0b

7D

0.7%

1Y

-24.6%

Updated

26 Mar, 2024

Data

Company Financials +

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

SHSE:688621 Stock Report

Market Cap: CN¥7.0b

688621 Stock Overview

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China.

688621 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth6/6
Past Performance3/6
Financial Health5/6
Dividends2/6

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Sun-Novo Pharmaceutical Research
Historical stock prices
Current Share PriceCN¥62.39
52 Week HighCN¥84.49
52 Week LowCN¥52.10
Beta0.13
1 Month Change3.19%
3 Month Change-4.15%
1 Year Change-24.64%
3 Year Changen/a
5 Year Changen/a
Change since IPO-27.27%

Recent News & Updates

Recent updates

Shareholder Returns

688621CN Life SciencesCN Market
7D0.7%-8.5%-2.9%
1Y-24.6%-42.6%-15.4%

Return vs Industry: 688621 exceeded the CN Life Sciences industry which returned -42.6% over the past year.

Return vs Market: 688621 underperformed the CN Market which returned -15.4% over the past year.

Price Volatility

Is 688621's price volatile compared to industry and market?
688621 volatility
688621 Average Weekly Movement7.2%
Life Sciences Industry Average Movement9.3%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.3%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 688621 has not had significant price volatility in the past 3 months.

Volatility Over Time: 688621's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20091,185Yujing Liuhttps://www.sun-novo.com

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform. It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Fundamentals Summary

How do Beijing Sun-Novo Pharmaceutical Research's earnings and revenue compare to its market cap?
688621 fundamental statistics
Market capCN¥6.99b
Earnings (TTM)CN¥194.05m
Revenue (TTM)CN¥953.90m

36.0x

P/E Ratio

7.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688621 income statement (TTM)
RevenueCN¥953.90m
Cost of RevenueCN¥0
Gross ProfitCN¥953.90m
Other ExpensesCN¥759.85m
EarningsCN¥194.05m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)1.73
Gross Margin100.00%
Net Profit Margin20.34%
Debt/Equity Ratio34.4%

How did 688621 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

24%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.